Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pharma’s Huge Bet on Immunotherapies
Pharma’s Huge Bet on Immunotherapies
Pharma’s Huge Bet on Immunotherapies
Submitted by
admin
on June 25, 2014 - 7:35am
Source:
Motley Fool
News Tags:
immunotherapy
anti-PD-1 immunotherapy
anti-PD-L1
MK-3475
Merck
nivolumab
Roche
Bristol-Myers Squibb
Headline:
Pharma’s Huge Bet on Immunotherapies
Do Not Allow Advertisers to Use My Personal information
